Feature TriSalus developing novel therapeutic solutions for liver and pancreatic tumors TriSalus Life Sciences (NASDAQ:TLSI) is addressing the mechanical and biologic barriers within the tumor microenvironment (TME) that make it challenging to successfully treat liver and pancreatic tumors. January 9, 2024